期刊文献+

国产哌拉西林/他唑巴坦及4种抗菌药物体外抗菌活性 被引量:2

THE ANTIBACTERIAL ACTIVITY IN VITRO OF DOMESTIC PIPERACILLIN/ TAZOBACTAM AND OTHER FOUR ANTIMICROBIAL AGENTS
下载PDF
导出
摘要 目的:对比研究哌拉西林/他唑巴坦(TZXL) 与抗菌药物特治星(TZX) 、哌拉西林(PIP)、特美汀(TMT) 和头孢他啶(CAZ) 对154 株临床分离菌的体外抗菌活性。方法:采用琼脂平板稀释法测定最低抑菌浓度(MIC)。结果:TZXL对革兰阳性球菌敏感率100% (34/34),抗菌活性与TZX、TMT一致,强于PIP、CAZ。对革兰阴性杆菌敏感率100 % ,与TMT相近,强于PIP及CAZ。尤其对产β- 内酰胺酶的金黄色葡萄球菌、假单胞菌属仍显示较高的抗菌活性。结论:TZXL与TZX的抗菌谱、体外抗菌活性基本一致,与TMT作用相似,比PIP、CAZ作用强。 AIM The antibacterial activities in vitro of piperacillin/tazobactam (TZXL)、tazoxin(TZX)、piperacillin(PIP)、timentin(TMT) and ceftazodine(CAZ) against 154 bacterials isolated from clinical patients were investigafed.METHODS MICs were determined by agar dillution method.RESULTS The susceptible rate of TZXL against G + coccus was 100%(34/34),TZXL 、TZX and TMT had the similar antibacterial activities which were higher than those of PIP and CAZ.The susceptible rate of TZXL against G - bacilli was 100%,and it had approximately antibacterial activity with TMT which was higher than PIP and CAZ.It is emphasized that TZXL also showed marked activity against Staphyococcus aureus and Pserdomonas spp.especially to β-lactamase positive strains.CONCLUSION The antimicrobial activities of TZXL and TZX were similor,which were slightly higher than that of TMT,and significantly stronger than those of PIP and CAZ.
出处 《解放军药学学报》 CAS 1999年第5期16-19,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 中国 哌拉西林 他唑巴坦 抗菌药 药物 抗菌活性 抗生素 Piperacillin/tazobactam Antibacterial activity
  • 相关文献

参考文献3

二级参考文献2

  • 1胡昌勤,中国抗生素杂志,1997年,22卷,189页
  • 2Yang C S,Biochem Pharmacol,1974年,23卷,3129页

共引文献41

同被引文献11

  • 1[1]Ferraro MJ, Craing WA, Eliopoulas G, et al. Performance standords for antimicrobial susceptibility: eighth informational supplement. NCCLS, 1998,18(1): 1.
  • 2[3]L. AKiko, T.Aystal structure of the E160A Wutant of Extended- spectrum β- lactamase Toho - 1 at 1. 8 A Reso Iution.J.Mol. Biol, 1999,285:2079-2087.
  • 3[4]Wise R. Beta - lactamase inhiters. J Antimicrob chemother,1982,9(supplb) :31
  • 4[5]Wiedemann B, Kliebe C, Kresken Met al,The epidemiology of β- lactamases, Jantimicrob chemother, 1989,24(arppl B): 1.
  • 5[6]Livermore DM. Determinants of the activity of β- lactamase inhibitor combination J Antimicrob chemother, 1993,31:9.
  • 6[8]Moellering RC.Meeting the callenges of β -lactamasts. J antimicrob Chemother, 1993,31(suppl A): 1 - 8.
  • 7[10]Balows A, Hausler WJ, Herrman KL, et al. Manal of clinical microbiology , 6th ed , Washinghton DC: American Soiety for Microbiology,1995:209.
  • 8吕媛,李家泰,单爱莲.β-内酰胺酶抑制剂与β-内酰胺类抗生素联合应用的抗菌作用评价[J].中国临床药理学杂志,1998,14(1):53-57. 被引量:48
  • 9张致平.碳青霉烯与青霉烯类抗生素研究开发的进展[J].中国药师,1998,1(2):68-70. 被引量:3
  • 10张致平.抗菌药研究的新进展[J].中国临床药理学杂志,2000,16(2):139-145. 被引量:17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部